0001062993-23-018390.txt : 20230921
0001062993-23-018390.hdr.sgml : 20230921
20230921203115
ACCESSION NUMBER: 0001062993-23-018390
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230815
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bloom Olivia Kyusuk
CENTRAL INDEX KEY: 0001501545
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20859
FILM NUMBER: 231270054
MAIL ADDRESS:
STREET 1: C/O GERON CORP
STREET 2: 230 CONSTITUTION DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GERON CORP
CENTRAL INDEX KEY: 0000886744
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 752287752
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6504737700
MAIL ADDRESS:
STREET 1: 919 EAST HILLSDALE BOULEVARD
STREET 2: SUITE 250
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GERON CORPORATION
DATE OF NAME CHANGE: 19960521
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-08-15
0000886744
GERON CORP
GERN
0001501545
Bloom Olivia Kyusuk
C/O GERON CORPORATION
919 E. HILLSDALE BLVD, SUITE 250
FOSTER CITY
CA
94404
0
1
0
0
EVP, Chief Financial Officer
0
Employee Stock Option (right to buy)
1.72
2023-08-15
4
A
0
250000
0
A
2023-08-15
2028-11-06
Common Stock
250000
250000
D
Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the
US FDA for imetelstat in lower risk MDS.
/s/ Olivia K. Bloom
2023-09-21